Atlas Trials

Hematological Neoplasms

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Hematological Neoplasms

RecordFirmDate
Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease (NCT03844360)Wei Zhao2016-01-31
Peg Interferon α-2b for Relapsed Hematological Malignancies After Allo-HSCT (NCT02634294)Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine2015-08-01
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies (NCT02223052)Celgene2014-10-27
ADVANCE: An Observational Study To Determine Bortezomib Safety and Effectiveness at First Relapse After Participation In First Line HOVON-49/50 Clinical Studies. (NCT00440479)Janssen-Cilag B.V.2006-09-01
Pegfilgrastim Versus Filgrastim After High-dose Chemotherapy (NCT00410696)Armando Santoro, MD2006-09-01
Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Hematological Diseases (NCT00582894)University of Oklahoma2005-02-01
VALEO: A Post Authorization Study, Designed to Learn More About the Safety and Effectiveness of the Use of Bortezomib in the Netherlands (NCT00440765)Janssen-Cilag B.V.2004-11-01
Granulocyte Transfusions in Hematological Patients With Febrile Neutropenia (NCT02544230)Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne2004-01-01

Track Hematological Neoplasms automatically

Every clearance here is in the API, with alerts when new ones post.